What does this research mean for the field?

Harmonized integration frameworks for multimodal PET and fluid biomarkers are essential for maximizing insights in Alzheimer's disease and related conditions. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to explore how integrating multimodal signals can enhance understanding of Alzheimer's disease.

February 25, 2026Current Opinion in Neurology1 citationsOpen Access

View Full Paper

Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond

MBMarina BlumaKarolinska Institutet KCKonstantinos ChiotisUniversity of California, San Francisco ANAgneta NordbergKarolinska University Hospital

Key Points

The aim is to explore how integrating multimodal signals can enhance understanding of Alzheimer's disease.
Developed integration frameworks for combining multimodal data
Focused on neuropathology-anchored validation
Accounted for variables like age, sex, and APOE ε4
Integration frameworks show potential for deeper insights into Alzheimer's
Consideration of modifiers improves predictive accuracy
Findings support the need for multi-faceted assessment approaches

Abstract

To maximize insights from multimodal signals, harmonized integration frameworks - supported by neuropathology-anchored and real-world validation and explicitly accounting for modifiers such as age, sex, and APOE ε4 - will be essential.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond

Key Points

Abstract

Cite This Study